Decreased overall survival in patients with brain metastases from non-small cell lung cancer with radiotherapy dose on the neurogenic niches

Key Points

• Decreased overall survival is observed in patients receiving radiotherapy for brain metastases.
• Patients treated with specific radiotherapy doses had a 25% reduction in survival rates over one year.
• Observational analysis on patient outcomes following radiotherapy for brain metastases suggests a critical link to dosage.
• Highlights a need for careful consideration of radiotherapy doses in patients with brain metastases.